Species Reactivity
Human
Application
WB, IHC
Concentration
500 ug/ml
Shipping Conditions
Ice packs
French translation
anticorps
Clonality
Polyclonal
Conjugation
Unconjugated
Estimated Turnaround Time
6-11 business days
Immunogen
PTGFRN (Pro406-Pro662)
Group
Polyclonals and antibodies
Restriction
For research use only. Not for diagnostic procedures.
Shelf life
Use Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Polyclonal Antibody before 1 year
Storage Temperature
Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Polyclonal Antibody should be stored at -20°C
Properties
If you buy Antibodies supplied by Biomatik they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
Tips
Our specialists recommend you to follow carefully the pre-registered instructions for Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Polyclonal Antibody
About
Polyclonals can be used for Western blot, immunohistochemistry on frozen slices or parrafin fixed tissues. The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera.
Ordering
To order Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Polyclonal Antibody , please use the Cat. Nr. CAU25345 and submit your purchase order by email or by fax. A discount is available for larger or bulk quantities, please contact us for more information
Description
Negative control peptides or isotypes available of the different species.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.